Prevalence of the Coprescription of Clinically Important Interacting Drug Combinations Involving Oral Anticancer Agents in Singapore: A Retrospective Database Study-Reference-Cited by-同舟云学术

Prevalence of the Coprescription of Clinically Important Interacting Drug Combinations Involving Oral Anticancer Agents in Singapore: A Retrospective Database Study

Published:2012-08 Issue:8 Volume:34 Page:1696-1704
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Ko Yu,Tan Sze-Ling Daphne,Chan Alexandre,Wong Yuet-Peng,Yong Wei-Peng,Ng Raymond Chee-Hui,Lim Siew-Woon,Salim Agus

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Drug-drug interactions in oncology: why are they important and can they be minimized?;Blower;Crit Rev Oncol Hematol,2005

2. Polypharmacy and inappropriate medication use in Singapore nursing homes;Mamun;Ann Acad Med Singapore,2004

3. Overview of the changing paradigm in cancer treatment: oral chemotherapy;Aisner;Am J Health Syst Pharm,2007

4. NCCN Task Force Report: oral chemotherapy;Weingart;J Natl Compr Canc Netw,2008

5. Answering patients' needs: oral alternatives to intravenous therapy;Borner;Oncologist,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Angiogenic Tyrosine Kinase Inhibitor-Related Toxicities Among Cancer Patients: A Systematic Review and Meta-Analysis;Targeted Oncology;2024-05-18

2. Contribution du dossier pharmaceutique dans l’analyse des interactions médicamenteuses lors de la rétrocession dans un centre de lutte contre le cancer;Annales Pharmaceutiques Françaises;2023-03

3. A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs;BMC Cancer;2022-05-14

4. Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management;Seminars in Oncology;2022-04

5. The optimization of combinatorial drug therapies: Strategies and laboratorial platforms;Drug Discovery Today;2021-11